Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biogen (BIIB)
NASDAQ:BIIB
Holding BIIB?
Track your performance easily
Biogen (BIIB) Ownership Overview
1.99% Insiders
38.10% Mutual Funds
54.59% Other Institutional Investors
5.32% Public Companies and Individual Investors
The ownership structure of Biogen (BIIB) stock is a mix of institutional, retail and individual investors. Approximately 92.69% of the company’s stock is owned by Institutional Investors, 1.99% is owned by Insiders and 5.32% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 26, 2024 | Priya Singhal Head Of Development | xxxxxxxxxxxxx | $57962 |
| Feb 21, 2024 | Priya Singhal Head Of Development | xxxxxxxxxxxxx | $23921 |
| Feb 20, 2024 | Eric Rowinsky Director | xxxxxxxxxxxxx | $101256 |
| Feb 13, 2024 | Priya Singhal Head Of Development | xxxxxxxxxxxxx | $100330 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $2781 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $215824 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $3760120 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $3805557 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,338,294 | Institution | 11.22% | 3,349,350,270 | |
| 15,004,206 | Institution | 10.30% | 3,075,862,230 | |
| 13,767,760 | Institution | 9.45% | 2,822,390,800 | |
| 9,153,861 | Institution | 6.28% | 1,876,541,505 | |
| 7,567,079 | Institution | 5.19% | 1,551,251,195 | |
| 6,009,743 | Institution | 4.13% | 1,231,997,315 | |
| 4,888,572 | Institution | 3.36% | 1,002,157,326 | |
| 4,558,453 | Institution | 3.13% | 934,482,865 | |
| 2,413,496 | Institution | 1.66% | 494,766,680 | |
| 2,243,237 | Institution | 1.54% | 459,863,585 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,767,760 | Institution | 9.45% | 2,822,390,800 | |
| 9,153,861 | Institution | 6.28% | 1,876,541,505 | |
| 4,558,453 | Institution | 3.13% | 934,482,865 | |
| 2,413,496 | Institution | 1.66% | 494,766,680 | |
| 2,243,237 | Institution | 1.54% | 459,863,585 | |
| 2,212,789 | Institution | 1.52% | 453,621,745 | |
| 1,780,695 | Institution | 1.22% | 365,042,475 | |
| 1,298,217 | Institution | 0.89% | 266,134,485 | |
| 1,173,500 | Institution | 0.81% | 240,567,500 | |
| 1,042,485 | Institution | 0.72% | 213,709,425 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,604,086 | Institution | 3.16% | 981,591,135 | |
| 3,779,089 | Institution | 2.59% | 805,701,775 | |
| 3,116,080 | Institution | 2.14% | 664,348,256 | |
| 2,840,735 | Institution | 1.95% | 582,350,675 | |
| 1,728,089 | Institution | 1.19% | 351,355,055 | |
| 1,728,089 | Institution | 1.19% | 351,355,055 | |
| 1,594,976 | Institution | 1.09% | 326,970,080 | |
| 1,196,404 | Institution | 0.82% | 255,073,333 | |
| 1,056,487 | Institution | 0.73% | 216,579,835 | |
| 1,063,278 | Institution | 0.73% | 216,185,683 |
FAQ
Who Owns Biogen (BIIB)?
According to the latest TipRanks data, approximately 54.59% of the company's stock is held by institutional investors, 1.99% is held by insiders, and 5.32% is held by retail investors.
What percentage of Biogen (BIIB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 54.59% of Biogen (BIIB) stock is held by institutional investors.
What percentage of Biogen (BIIB) stock is held by retail investors?
According to the latest TipRanks data, approximately 5.32% of Biogen (BIIB) stock is held by retail investors.
Who owns the most shares of Biogen (BIIB)?
Theofanis Kolokotrones owns the most shares of Biogen (BIIB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.